Bechem M, Schramm M
J Mol Cell Cardiol. 1987 May;19 Suppl 2:63-75. doi: 10.1016/s0022-2828(87)80005-6.
In contrast to nifedipine-like calcium antagonists, calcium agonistic 1,4-dihydropyridines have vasoconstricting and positive inotropic properties. BAY K 8644 has become the prototype of this new class. Its enantiomers show opposite effects on the calcium channel: one acts as a calcium agonist with the pharmacological profile of the racemic compound, its antipode has calcium antagonistic effects at 10 times higher concentrations. Voltage clamp studies reveal calcium current increasing effects at 3 X 10(-8) mol/l BAY K 8644, while the current is reduced at 3 X 10(-6) mol/l. Analysis of the calcium current activation and deactivation kinetics shows that BAY K 8644 leaves the mean closed times of the calcium channel unchanged while it increases the mean open times. From these data a reaction model of drug action is derived, suggesting that BAY K 8644 binds only to the open state of the Ca-channel.
与硝苯地平类钙拮抗剂相反,钙激动剂1,4 -二氢吡啶具有血管收缩和正性肌力特性。BAY K 8644已成为这类新药的原型。其对映体对钙通道显示出相反的作用:一种表现为钙激动剂,具有外消旋化合物的药理学特征,其对映体在浓度高10倍时具有钙拮抗作用。电压钳研究显示,在3×10(-8) mol/l的BAY K 8644作用下钙电流增强,而在3×10(-6) mol/l时电流降低。对钙电流激活和失活动力学的分析表明,BAY K 8644使钙通道的平均关闭时间保持不变,而增加了平均开放时间。从这些数据推导出药物作用的反应模型,表明BAY K 8644仅与钙通道的开放状态结合。